1 The pharmacological characteristics of muscarinic receptors in rat isolated uterus were studied in ovariectomized (ov.) and sham operated (sh.) animals. 2 Competition radioligand binding studies, using uterine membranes and [ 3 H]-NMS, were undertaken with several muscarinic receptor antagonists. Most of the antagonists indicated a onesite ®t with apparent a nity estimates (pK i ) unchanged by ovariectomy. The selective M 2 antagonist, tripitramine revealed high (representing 33+8 and 38+2%) and low (67+8 and 62+2%) a nity binding sites in both sh. and ov. rat uterus, respectively. These sites likely represented muscarinic M 2 and M 3 receptors and the proportions were not signi®cantly di erent in the two conditions. 3 Carbachol induced concentration-dependent contractions which were surmountably antagonized by several muscarinic receptor antagonists (pK B , sh.; ov.): zamifenacin (9.19; 9.18), p-F-HHSiD (8.50; 9.06), tripitramine (7.23; 7.54), himbacine (7.21; 7.41), methoctramine (6.79; 7.49), pirenzepine (6.48; 7.21), AF DX 116 (6.26; 6.61), MTx 3 (57.00; 57.00) and PD 102807 (57.00; 57.00). 4 The apparent a nity values obtained in functional studies using the uteri from both sh. and ov. animals correlated most closely with values reported at human recombinant muscarinic M 3 receptors. This suggests that the muscarinic M 3 receptor mediates contraction under both conditions. 5 Radioligand binding experiments indicate the presence of M 2 receptors, in addition to M 3 receptors, which probably explains the discrepancies between functional and binding a nities. These data further suggest that the pharmacological pro®le and proportions of the two populations of muscarinic receptors are una ected by ovariectomy.